• Equipment
• Refrigerators and Ice Machines
• Liquid Nitrogen Supply Tanks
• Cryogenic Storage Systems
On the basis of analysis, the global biobank market is segmented into:
• Human tissue and tumor cells
• Bio-fluids
• Stem cells
• Umbilical cord
• DNA/RNA
On the basis of application, the global biobank market is segmented into:
• Biobanking
• Regenerative Medicine
• Drug Discovery
On the basis of end-user, the global biobank market is segmented into:
• Diagnostic Clinical Centers
• Research Organizations
• Others
Ask For Discount Before Purchasing This Business Report @
https://www.coherentmarketinsights.com/insight/request-discount/896
Increasing funds from National Institute of Health, USA is expected to dominate North America
in the global biobank market
Regional segmentation of the global biobank market by Coherent Market Insights comprises
North America, Latin America, Europe, and Asia-Pacific. According to the research conducted
by BioMed Central, United States, stored 270 million specimens in biobanks in 2008, with the
rate of new samples collected being 20 million every year. North America is expected to
dominate the global biobank market with the increasing funds from healthcare organizations
like National Institute of Health (NIH) and National Cancer Institute, which facilitate biobanks
across the U.S. Additionally, the rising interest in biotechology has facilitated collaborations of
biobanks which is expected to augment the global biobank market in the forecast period. Asia-
Pacific is expected to have an opportunistic biobank market owing to the rise in diseases,